Records containing: Lennox-Gastaut Syndrome
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2025-12-03A Phase 2, Multicenter, Open-label, Long-term Safety Study of LP352 in Subjects With Developmental and Epileptic Encephalopathy Who Completed Study LP352-201 and Are Candidates for Continuous Treatment for Up to 52 Weeks
-
CLINICAL_TRIALS study record update · 2023-02-21ClinicalTrials.gov study NCT02175173
-
CLINICAL_TRIALS study record update · 2022-09-01An Open-Label Exploratory Investigation of Cognitive Outcomes With Cannabidiol Oral Solution (EPIDIOLEX®; GWP42003-P)
-
CLINICAL_TRIALS study record update · 2022-07-14Double Blind, Randomised, Cross-over Study Melatonin Versus Placebo in the Lennox-Gastaut Syndrome: Neurophysiological and Neuropsychological Effects
-
CLINICAL_TRIALS study record update · 2022-02-03An Open Label Extension Study to Investigate the Safety of Cannabidiol (GWP42003-P; CBD) in Children and Adults With Inadequately Controlled Dravet or Lennox-Gastaut Syndromes.
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2022-01-03The Effects of Cannabidiol (CBD) on Electrical and Autonomic Cardiac Function in Children
-
CLINICAL_TRIALS study record update · 2021-02-18A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of TAK-935 (OV935) as an Adjunctive Therapy in Pediatric Patients With Developmental and/or Epileptic Encephalopathies
-
CLINICAL_TRIALS study record update · 2019-08-06A Multicenter, Randomized, Controlled, Open-label Study to Evaluate the Cognitive Development Effects and Safety, and Pharmacokinetics of Adjunctive Rufinamide Treatment in Pediatric Subjects 1 to Less Than 4 Years of Age With Inadequately Controlled Lennox-Gastaut Syndrome
-
CLINICAL_TRIALS study record update · 2019-03-11A Long Term Extension Study of E2080 in Lennox-Gastaut Patients
-
CLINICAL_TRIALS study record update · 2018-11-13Epilepsy Phenome/Genome Project: A Phenotype/Genotype Analysis of Epilepsy
-
CLINICAL_TRIALS study record update · 2018-07-27A Randomized, Double-blind, Placebo-controlled Study to Investigate the Efficacy and Safety of Cannabidiol (GWP42003-P; CBD) as Adjunctive Treatment for Seizures Associated With Lennox-Gastaut Syndrome in Children and Adults.
-
CLINICAL_TRIALS study record update · 2018-04-30Turmeric as Treatment in Epilepsy
-
CLINICAL_TRIALS study record update · 2018-01-04A Multicenter, Randomized, Double-blind, Placebo-controlled, Interventional Study to Assess the Safety and Efficacy of Pharmaceutical Cannabidiol Oral Solution as an Adjunctive Therapy for Treatment of Subjects With Inadequately Controlled Lennox-Gastaut Syndrome
-
CLINICAL_TRIALS study record update · 2016-10-11The Clinical Research on PINS Vagus Nerve Stimulator for Treatment of Lennox-Gastaut in Children
-
CLINICAL_TRIALS study record update · 2016-06-29Transcranial Direct Current Stimulation for Treatment of Childhood Pharmacoresistant Lennox-Gastaut Syndrome, A Pilot Study
-
CLINICAL_TRIALS study record update · 2016-05-04European Registry of Anti-epileptic Drug Use in Patients With Lennox-Gastaut Syndrome (LGS).
-
CLINICAL_TRIALS study record update · 2013-11-21A Placebo-Controlled, Double-Blind Comparative Study of E2080 in Lennox-Gastaut Syndrome Patients
-
CLINICAL_TRIALS study record update · 2013-05-06Safety and Effectiveness of Open-Label Clobazam in Subjects With Lennox-Gastaut Syndrome
-
CLINICAL_TRIALS study record update · 2006-12-22Efficacy of the Ketogenic Diet -- a Blinded Study